FDA issued a Warning Letter to Customceutical Compounding on 8/25/2020 as a result of this inspection.
FDA investigators audited the Customceutical Compounding - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 08 Mar 2019.
Add To Cart
- Category: Human Drugs
- Inspection end: 08 Mar 2019
- Location: Phoenix, United States
- FEI: 3014083318